Dr Federico Paoletti tells us why he founded Exogene and his hopes for innovating T-cell receptor-based cancer immunotherapies using AI. He also discusses the challenges he faces today, having raised a seed round earlier this year.

Federico also recommends a book every founder should read as well as a series that sheds unusual insight into the life of a start-up.

Exogene is based in Oxford UK and supported by the Oxford BioEscalator.